TrialSignal
Clinical trial intelligence report
Free-Base Nicotine or Nicotine Salt e-Liquids in Current E-Cigarette Smokers, PeloPET
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jun 25, 2026
Report code
NCT05455086-Jun 25, 2026
NCT ID
NCT05455086
Status
COMPLETED
Phase
Completed
Sponsor
Ohio State University Comprehensive Cancer Center
Executive brief
Investment-Ready Snapshot
The PeloPET study, sponsored by the Ohio State University Comprehensive Cancer Center, investigates the effects of free-base nicotine versus nicotine salt e-liquids on puffing behavior and nicotine absorption. Given the increasing prevalence of e-cigarette use and the ongoing regulatory scrutiny in the tobacco and nicotine market, the findings could provide critical insights for public health officials and regulators. This study may influence product formulation and marketing strategies for e-cigarette manufacturers, as well as inform potential future therapeutic applications targeting nicotine addiction. The competitive landscape includes major e-cigarette brands and emerging players focusing on product safety and efficacy.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT05455086
Indication
Cigarette Smoking-Related Carcinoma
Modality
behavioral intervention
Target
Nicotine absorption and distribution in the brain and respiratory tract.
Intervention
Cigarette Smoking, Cigarette Smoking, Cigarette Smoking, Cigarette Smoking, Computed Tomography, Positron Emission Tomography, Questionnaire Administration
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.